The Bandiagara Malaria Project has been conducting malaria vaccine research since 1997. They have completed two malaria vaccine trials and published 20 scientific papers. Their research has focused on two candidate vaccines: RTS,S and AMA-1. RTS,S is a recombinant protein combining the circumsporozoite protein with hepatitis B surface antigen and an adjuvant. It has shown modest efficacy in clinical trials. AMA-1 is based on the apical membrane antigen-1 involved in erythrocyte invasion. Antibodies against AMA-1 can block merozoite invasion into red blood cells. The project is a collaboration between the University of Bamako in Mali, the University of Maryland, and